2m 2m 2m 2m 2m 2m 2m
KINIKSA PHARMA (KNSA)
NASDAQ
$76.51+$0.23 (+0.31%)
Price as of Sep 11, 2026 7:30 PM EDT- $3.2BMarket Cap
- 105.58%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
KINIKSA PHARMA (KNSA)
$76.51+$0.23 (+0.31%)
KNSA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $76.27 | ||
Change | -$0.21 (-0.27%) | ||
Open | $77.70 | ||
High | $78.59 | ||
Low | $76.14 | ||
Previous Close | $76.48 | ||
Volume | 795,061 | ||
30-Day Average Volume | 492,127 | ||
1-Week Change | -2.10% | ||
1-Month Change | -1.97% | ||
1-Year Change | 105.58% | ||
3-Year Change | 337.58% | ||
5-Year Change | 515.08% | ||
Fundamentals | |||
Shares Outstanding | 42.0M | ||
Total Assets | $896.1M | ||
Market Cap | $3.2B | ||
Enterprise Value | $3.0B | ||
Period: QTR TTM FY | |||
Revenue | $243.6M | ||
Net Income | $25.4M | ||
Free Cash Flow | $46.5M | ||
EBIT | $31.1M | ||
EBITDA | $31.6M | ||
Net Working Capital | $497.4M | ||
EPS | $0.30 | ||
Enterprise Value/EBITDA | 96 | ||
Enterprise Value/Revenue | 12 | ||
P/B | 5 | ||
P/E | 254 | ||
PEG | 23 | ||
Price/Free Cash Flow | 69 | ||
Price/Operating Cash Flow | 68 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue